Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 03, 2021

SELL
$282.99 - $369.05 $101,310 - $132,119
-358 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$259.0 - $414.71 $9,065 - $14,514
-35 Reduced 8.91%
358 $124,000
Q1 2021

May 13, 2021

SELL
$242.95 - $284.63 $12,390 - $14,516
-51 Reduced 11.49%
393 $110,000
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $7,560 - $11,380
-32 Reduced 6.72%
444 $109,000
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $196,064 - $259,652
-758 Reduced 61.43%
476 $127,000
Q1 2020

Apr 14, 2020

BUY
$268.85 - $341.04 $195,722 - $248,277
728 Added 143.87%
1,234 $390,000
Q4 2019

Feb 24, 2020

SELL
$220.06 - $304.07 $2.38 Million - $3.29 Million
-10,818 Reduced 95.53%
506 $150,000
Q3 2019

Oct 29, 2019

BUY
$217.44 - $243.88 $88,932 - $99,746
409 Added 3.75%
11,324 $2.64 Million
Q2 2019

Jul 19, 2019

BUY
$219.29 - $241.72 $153,722 - $169,445
701 Added 6.86%
10,915 $2.55 Million
Q1 2019

May 09, 2019

BUY
$216.71 - $338.96 $429,519 - $671,818
1,982 Added 24.08%
10,214 $2.41 Million
Q4 2018

Jan 15, 2019

SELL
$278.5 - $352.75 $176,847 - $223,996
-635 Reduced 7.16%
8,232 $2.48 Million
Q3 2018

Oct 18, 2018

BUY
$293.51 - $383.83 $317,284 - $414,920
1,081 Added 13.88%
8,867 $3.13 Million
Q2 2018

Aug 01, 2018

BUY
$257.52 - $306.91 $145,756 - $173,711
566 Added 7.84%
7,786 $2.26 Million
Q1 2018

Apr 20, 2018

BUY
$260.13 - $367.91 $673,736 - $952,886
2,590 Added 55.94%
7,220 $1.98 Million
Q4 2017

Feb 05, 2018

BUY
$307.64 - $344.58 $1.42 Million - $1.6 Million
4,630
4,630 $1.48 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ima Wealth, Inc. Portfolio

Follow Ima Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ima Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ima Wealth, Inc. with notifications on news.